Literature DB >> 17117421

Different levodopa actions on the extracellular dopamine pools in the rat striatum.

M Rodríguez1, I Morales, J L González-Mora, I Gómez, M Sabaté, J G Dopico, M C Rodríguez-Oroz, J A Obeso.   

Abstract

Levodopa has been the mainstay treatment for Parkinson's disease for several decades, but the precise mechanism for its therapeutic action is still not well understood. To date, little distinction has been made between the effects of levodopa on the different brain DA pools. We studied the levodopa action on two extracellular DA pools: one was analyzed by microdialysis (often considered as indicative of volume transmission) and the other by in vivo amperometry during nigrostriatal cell stimulation (more indicative of neurotransmission). Levodopa administration induced a moderate (increased 200%) and tardy (began at 60 min) increase in the DA-pool measured by microdialysis, an effect that increased (increased 500%) and accelerated (began at 10 min) after DA-cell degeneration. Levodopa action on the DA-pool measured by amperometry was very fast (10 min) and prominent (increased 600%) in normal rats. The DA-denervated striatum showed a fast exhaustion during cell stimulation, which prevented further study of the levodopa effect on the DA amperometry-pool under this condition. This study suggests a different kinetic for levodopa action on the volume transmitter and neurotransmitter DA-pool, showing marked changes in levodopa action in the denervated striatum. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17117421     DOI: 10.1002/syn.20342

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  10 in total

1.  Influence of phasic and tonic dopamine release on receptor activation.

Authors:  Jakob K Dreyer; Kjartan F Herrik; Rune W Berg; Jørn D Hounsgaard
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

2.  Compensatory weight gain due to dopaminergic hypofunction: new evidence and own incidental observations.

Authors:  Julia Reinholz; Oliver Skopp; Caterina Breitenstein; Iwo Bohr; Hilke Winterhoff; Stefan Knecht
Journal:  Nutr Metab (Lond)       Date:  2008-12-01       Impact factor: 4.169

3.  Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment.

Authors:  Pauline Belujon; Daniel J Lodge; Anthony A Grace
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

4.  Fast-scan cyclic voltammetry demonstrates that L-DOPA produces dose-dependent, regionally selective bimodal effects on striatal dopamine kinetics in vivo.

Authors:  Rashed Harun; Kristin M Hare; Elizabeth M Brough; Miranda J Munoz; Christine M Grassi; Gonzalo E Torres; Anthony A Grace; Amy K Wagner
Journal:  J Neurochem       Date:  2016-01-13       Impact factor: 5.372

5.  Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.

Authors:  Christopher D Howard; Elissa D Pastuzyn; Melissa L Barker-Haliski; Paul A Garris; Kristen A Keefe
Journal:  J Neurochem       Date:  2013-04-01       Impact factor: 5.372

6.  Unmasking the Effects of L-DOPA on Rapid Dopamine Signaling with an Improved Approach for Nafion Coating Carbon-Fiber Microelectrodes.

Authors:  Lingjiao Qi; Elina Thomas; Stephanie H White; Samantha K Smith; Christie A Lee; Leslie R Wilson; Leslie A Sombers
Journal:  Anal Chem       Date:  2016-08-03       Impact factor: 6.986

7.  Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.

Authors:  M G Morgese; T Cassano; S Gaetani; T Macheda; L Laconca; P Dipasquale; L Ferraro; T Antonelli; V Cuomo; A Giuffrida
Journal:  Neurochem Int       Date:  2008-11-01       Impact factor: 3.921

8.  The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.

Authors:  John Liggins; Robert O Pihl; Chawki Benkelfat; Marco Leyton
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

Review 9.  Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.

Authors:  Michael J Beckstead; Rebecca D Howell
Journal:  Exp Neurol       Date:  2021-03-20       Impact factor: 5.620

10.  Effects of daily L-dopa administration on learning and brain structure in older adults undergoing cognitive training: a randomised clinical trial.

Authors:  Alexander V Lebedev; Jonna Nilsson; Joanna Lindström; William Fredborg; Ulrika Akenine; Carolina Hillilä; Pia Andersen; Gabriela Spulber; Elizabeth C M de Lange; Dirk-Jan van den Berg; Miia Kivipelto; Martin Lövdén
Journal:  Sci Rep       Date:  2020-03-23       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.